Concomitantly, we investigated whether CADM1 expression could be restored in cervical cancer cell lines expressing methylated CADM1 that were treated with the demethylation reagent 5-aza-2′-deoxycytidine (5-aza-dC). The gene discussed is CADM1; the disease is cervical cancer.